Free Case Evaluation
FILL OUT THE FORM BELOW
TO REQUEST YOUR CASE REVIEW
Latest Philips CPAP Lawsuit Updates
Our attorneys are reviewing personal injury claims from patients who used recalled Philips CPAP, BiPAP, and mechanical ventilator devices and were later diagnosed with cancer, lung disease, or other respiratory conditions linked to the polyester-based polyurethane (PE-PUR) sound abatement foam.
Personal injury claims are consolidated in MDL 3014, In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation, in the U.S. District Court for the Western District of Pennsylvania before Judge Joy Flowers Conti.
To qualify, claimants generally need a documented medical condition linked to PE-PUR foam exposure plus proof of use of a recalled device.
Fill out the form to check your eligibility and find out if you qualify to file a claim.
The litigation alleges that Philips Respironics knew the PE-PUR sound abatement foam in millions of devices could degrade, off-gas volatile organic compounds, and shed black particulate matter directly into patients' airways. The company issued a Class I recall in June 2021, by which point patients had used the devices nightly for years.
Conditions being investigated:
- Lung Cancer
- Kidney Cancer
- Liver Cancer
- Hematologic (Blood) Cancers
- Pulmonary Fibrosis
- Reactive Airway Disease
- Severe Asthma (New Onset)
- Chronic Bronchitis
- Acute Respiratory Distress Syndrome
2023 Settlements (Resolved): Philips agreed to pay $479 million to settle economic-loss claims (device replacement and refund) and approximately $1.1 billion to settle a separate consolidated personal-injury settlement program covering certain claims. Personal injury claims continue for users who opted out, who developed serious conditions later, or whose cases fall outside the settlement matrix.
FDA Update: Philips signed a consent decree with the FDA in April 2024 covering U.S. operations through 2029. The company is barred from selling new sleep therapy devices in the U.S. until specified compliance milestones are met.
Table of Contents
[show]- The June 2021 Recall and What Went Wrong
- Conditions Linked to PE-PUR Foam Exposure
- Recalled Devices: Models and Serial Numbers
- MDL 3014 Status: Court, Judge, and Settlement Programs
- Who Qualifies to File a Personal Injury Claim
- Compensation Available in CPAP Injury Claims
- How to File and Statute of Limitations
Philips CPAP Recall Litigation: The Largest Medical Device Recall of the Decade
(Personal Injury Claims After the PE-PUR Foam Recall)
Philips Respironics recalled approximately 15 million CPAP, BiPAP, and mechanical ventilator devices on June 14, 2021. The recall was triggered by reports that the polyester-based polyurethane sound abatement foam inside the devices was breaking down.
When the foam degrades, two things happen. First, black particulate debris sheds and can be inhaled or swallowed by the patient. Second, the foam off-gases volatile organic compounds, including dimethyl diazene and toluene diamine, both flagged by FDA as potential carcinogens.
Patients with obstructive sleep apnea (OSA), central sleep apnea (CSA), and complex sleep apnea used these devices nightly to maintain a prescribed AHI (apnea-hypopnea index) target. Many used them for 6 to 8 hours every night, for years, before the recall. Mechanical ventilator users (Trilogy 100 and 200, used by ALS, severe COPD, and pediatric patients) had foam exposure 24 hours a day. The cumulative inhalation and ingestion is what drives the personal injury litigation.
"Philips knew about the foam degradation for years before the recall. Internal records show complaints dating back to at least 2015."
The Recall Timeline and What Philips Knew
Philips issued the field safety notice on June 14, 2021, classifying it as a Class I recall (the FDA's most serious recall category, indicating reasonable probability that use could cause serious adverse health consequences or death).
The company's public statements framed the foam degradation as a recently discovered issue. Discovery in MDL 3014 has produced internal documents that contradict that framing. Engineering memos, customer-complaint logs, and quality reports show that Philips received reports of foam degradation as early as 2015. The company evaluated alternative materials. It did not warn users.
FDA inspections after the recall identified more than 100 deaths reported to Philips that the company had not properly investigated or reported under medical-device reporting rules.
The April 2024 consent decree between Philips and the FDA acknowledges the failures. Philips is now barred from selling new sleep therapy devices in the U.S. market until it meets specific compliance benchmarks.
For users, the legal question is straightforward: did the foam degradation cause the medical condition you developed, and is your claim within the applicable filing window?
- Class I recall affecting an estimated 15 million devices in the U.S.
- FDA consent decree restricting Philips from selling new devices through 2029
- Internal documents showing Philips knew of the foam issue years before recall
- Two-track settlement structure already in place ($479M economic + ~$1.1B PI)
Conditions Linked to PE-PUR Foam Exposure
The medical literature on PE-PUR degradation byproducts is still developing. The FDA's recall notice flagged the following potential health risks: irritation (skin, eye, respiratory), inflammatory response, headache, asthma, adverse effects on other organs (kidney, liver), and toxic carcinogenic effects.
The MDL has organized claims into tiers based on diagnosis severity and the strength of the causal link.
Tier 1: Cancer Claims
Hard Truth: Lung cancer, kidney cancer, liver cancer, and certain hematologic cancers (lymphoma, multiple myeloma) sit at the top of the tier matrix. The volatile organic compounds released from degrading PE-PUR foam include compounds with documented carcinogenic activity. Cancer cases require pathology, treatment records, and a use history showing nightly device exposure for years prior to diagnosis.
Tier 2: Severe Respiratory and Pulmonary Conditions
Hard Truth: Pulmonary fibrosis, reactive airway disease, severe new-onset asthma, chronic bronchitis, and bronchiectasis fit here. These conditions reflect direct injury from inhaling foam particulate and degradation gases. Causation evidence is often strongest because the airway is the immediate exposure pathway.
Tier 3: Inflammatory and Functional Injuries
Hard Truth: Persistent headaches, sinus infections, chronic cough, dizziness, kidney function impairment, and liver function impairment fall in this tier. The settlement matrix and bellwether tracks treat these conditions differently. Some are eligible for streamlined settlement; others are excluded entirely.
Recalled Devices: What Was Affected
The recall covered three product categories. Knowing which device you used matters for the claim.
Recalled Philips Devices
Most affected: DreamStation, DreamStation Go, SystemOne (Q-Series), DreamStation ASV. CPAP machines deliver continuous positive airway pressure for obstructive sleep apnea. Users wear them nightly for 6 to 8 hours, often for years. Cumulative inhalation exposure is the central injury mechanism.
Affected models: DreamStation BiPAP autoSV, DreamStation BiPAP AVAPS, DreamStation BiPAP S/T, OmniLab Advanced+. BiPAP delivers two pressure levels and is used for more complex sleep apnea, COPD, and certain neuromuscular conditions. Users tend to be sicker at baseline, which affects causation analysis.
Affected models: Trilogy 100, Trilogy 200, Garbin Plus, Aeris, A-Series BiPAP Hybrid A30. Mechanical ventilators support patients who cannot breathe on their own. Patient populations include ALS, severe COPD, and pediatric users. Foam exposure for ventilator-dependent patients runs 24 hours per day, not just at night.
Philips offered DreamStation 2 devices as recall replacements. Subsequent reports identified ozone-related issues in some replacements, leading to additional FDA scrutiny. If your replacement device caused or worsened symptoms, your claim should reference both the original recalled device and the replacement.
The Two-Track Settlement Structure
The litigation has resolved on two tracks for many claimants. The first track (economic loss) compensated users for the value of the device, replacement costs, and out-of-pocket expenses. Philips agreed to pay $479 million plus a separate consumer-medical-monitoring component.
The second track (personal injury) covers users who developed medical conditions from foam exposure. Philips entered a multi-billion-dollar consolidated settlement program for personal injury claims. The matrix tiers payouts by diagnosis and use history.
Some claimants opted out. Some claimants developed conditions after the settlement window closed and need to file new individual claims. Some claims fall outside the settlement matrix entirely. The bellwether process and individual filings continue.
HARD TRUTH: The settlement programs are administered, not automatic. Eligibility, documentation, and tier placement all require active legal work. A claim that fits the matrix can still be denied without the right submission.
MDL 3014 at a Glance
Key procedural facts every claimant should understand:
- Case caption: In re: Philips Recalled CPAP, Bi-Level PAP, and Mechanical Ventilator Products Liability Litigation, MDL No. 3014
- Court: U.S. District Court for the Western District of Pennsylvania
- Judge: Hon. Joy Flowers Conti
- Centralized: October 8, 2021, by the JPML
- Recall date: June 14, 2021 (Class I recall)
- Devices recalled: Approximately 15 million in the U.S.
- Economic settlement: $479 million (resolved 2023)
- Personal injury settlement program: Approximately $1.1 billion (consolidated PI program)
- FDA consent decree: April 2024 (restricting U.S. sales through 2029)
The MDL coordinates pretrial work for claims that did not resolve through the consolidated settlement programs. Bellwether trials are being prepared for non-settled categories.
Who Qualifies to File a Philips CPAP Lawsuit
Eligibility centers on three things: a recalled device, a documented qualifying medical condition, and a timely filing.
- Recalled device: Use of any device on the June 2021 Philips recall list (CPAP, BiPAP, or mechanical ventilator). Serial numbers, prescription records, DME supplier records, and insurance claims all support this.
- Use period: Use of the recalled device prior to the recall and for a period long enough to support cumulative exposure (most claims involve months to years of nightly use)
- Qualifying diagnosis: Lung cancer, kidney cancer, liver cancer, hematologic cancer, pulmonary fibrosis, reactive airway disease, severe new-onset asthma, chronic bronchitis, or another condition listed in the settlement matrix or recognized in the MDL
- Diagnosis date: Diagnosis within the applicable statute of limitations and discovery-rule window
- Documentation: Device records, medical records, pathology reports, treatment records
Many claims that initially appeared ineligible turn out to qualify under the discovery rule, particularly when later diagnosis revealed a connection patients did not understand at the time.
Compensation Available in Philips CPAP Claims
Damages cover both economic and non-economic losses.
Economic damages: cost of the recalled device, replacement device costs, medical bills (treatment for cancer, pulmonary care, hospitalizations), lost wages, and lost earning capacity.
Non-economic damages: pain and suffering, emotional distress, loss of consortium, diminished quality of life. Cancer diagnoses with significant treatment burden anchor the higher end of the matrix.
Wrongful death damages: if a CPAP user died of a foam-linked cancer or respiratory disease, surviving family may recover under state wrongful death statutes plus a survival action for the decedent's pre-death pain and suffering. See our coverage of wrongful death claims.
Punitive damages: available where the evidence supports a finding that Philips knew about the foam issue and continued to sell the devices without warning. Internal Philips documents make this a credible argument.
Settlement Tier Structure
The consolidated PI settlement program tiers payouts by diagnosis, severity, treatment burden, age at diagnosis, and use duration. Specific tier values are confidential, but cancer cases with extended treatment generally sit highest. Lower-tier conditions (chronic cough, recurring sinus issues) sit much lower. Tiered matrices like this one appear across other product-liability MDLs our attorneys are reviewing.
Cases that fall outside the matrix proceed to individual resolution through the MDL bellwether process or through state-court litigation. Outcome depends on the specific facts and the strength of the causation evidence.
For broader context on injury valuation, see our explanation of what your injury case is worth and how settlement values are calculated.
Filing Deadlines and Key Procedural Issues
For latent-injury cases, the SOL clock typically starts when a reasonable person would have linked the cancer or pulmonary disease to CPAP use, not on the date of first device exposure. The June 2021 recall is a common discovery date, though earlier discovery dates apply for users who tracked complaints sooner.
Claimants who opted out of the consolidated PI settlement program retain individual claims through MDL 3014. Opt-outs file directly in the W.D. Pa. and proceed through the bellwether process. Whether opt-out was the right choice depends on diagnosis severity and the strength of the individual case.
Some cancers develop years after exposure. Users diagnosed after the original settlement window may still qualify under the discovery rule. The MDL accepts new individual filings; whether they fold into a settlement matrix or proceed independently depends on the specific facts.
Replacement DreamStation 2 devices generated their own complaints, including ozone-related concerns. If your replacement device caused or worsened symptoms, document its model, serial number, and the timeline of use alongside the original recalled device.
Defenses and Hurdles in CPAP Personal Injury Cases
The defendants will challenge two things hardest. First, specific causation. Many CPAP users have underlying health conditions (obesity, smoking history, sleep apnea itself, hypertension) that complicate the causation analysis. The defense will argue these alternative causes explain the cancer or respiratory disease.
Second, the strength of the toxicology evidence on PE-PUR degradation byproducts. Studies on cumulative inhalation of these specific compounds at the doses CPAP users experienced are still developing. Plaintiffs rely on expert toxicologists, internal Philips documents, and FDA findings to bridge the gap.
The 2024 FDA consent decree shifts the landscape in plaintiffs' favor. Federal regulatory acknowledgment of the company's failures is admissible context.
The medical-device parallel is the Paragard IUD breakage litigation, where federal preemption and FDA premarket approval defenses run on similar lines. The toxic-inhalation parallel is the AFFF firefighting foam litigation, which involves comparable cumulative-exposure causation arguments and federal regulatory backdrop.
How to File a Philips CPAP Lawsuit
Step one: free case review. Share your device model, your use history, and your diagnosis.
Step two: device documentation. We pull DME supplier records, prescription records, and insurance claims to establish use of the recalled device.
Step three: medical record collection. Pathology reports, pulmonary function tests, oncology notes, and treatment records confirm the qualifying diagnosis.
Step four: filing. Most claims are filed directly in MDL 3014 in the W.D. Pa. Settlement-program-eligible claims are submitted to the program. Opt-out claims proceed through the MDL.
Step five: resolution. Settlement, individual MDL trial, or in some cases, return to state court for resolution. Outcome depends on the specific facts.
Contingency fee. No money out of pocket. No fee unless we recover compensation for you.
Filing Time Window Limitations: Why Sooner Is Better Than Later
The original settlement program windows have closed. New filings now proceed individually through the MDL. Statutes of limitations vary by state and by injury type. Some states' product-liability SOLs are short, and statutes of repose can bar otherwise valid claims.
If you used a recalled Philips device and have been diagnosed with cancer, pulmonary fibrosis, or another listed condition, the case review costs nothing and clarifies your options. Waiting closes doors that need not close.
Philips CPAP Lawsuit: Frequently Asked Questions
- Q: Is my Philips CPAP recalled?
-
A: If your device is a DreamStation, DreamStation Go, SystemOne (Q-Series), DreamStation ASV, DreamStation BiPAP autoSV, DreamStation BiPAP AVAPS, DreamStation BiPAP S/T, OmniLab Advanced+, Trilogy 100, Trilogy 200, Garbin Plus, Aeris, or A-Series BiPAP Hybrid A30 manufactured before April 26, 2021, it is on the recall list. Check the serial number on the bottom of the device against Philips' recall lookup tool. Replacement DreamStation 2 devices have generated separate complaints and may also support a claim.
- Q: What conditions qualify for a Philips CPAP lawsuit?
-
A: Tier 1 (cancer): lung cancer, kidney cancer, liver cancer, hematologic cancers including lymphoma and multiple myeloma. Tier 2 (severe respiratory): pulmonary fibrosis, reactive airway disease, severe new-onset asthma, chronic bronchitis, bronchiectasis. Tier 3 (functional and inflammatory): chronic cough, recurring sinus issues, kidney function impairment, liver function impairment, headaches. Tier placement affects settlement value. A Philips CPAP attorney can confirm where your diagnosis sits.
- Q: I missed the original Philips settlement program. Can I still file?
-
A: Possibly yes. Cancers and pulmonary diseases that manifested after the original settlement window remain eligible under the discovery rule in most states. New individual cases continue to be filed in MDL 3014. Your filing window depends on your state's statute of limitations and when a reasonable person would have linked the diagnosis to CPAP use. The free case review confirms eligibility.
- Q: Are CPAP replacement (DreamStation 2) devices part of the lawsuit?
-
A: Replacement DreamStation 2 devices generated their own complaints, including ozone-related concerns. If your replacement device caused or worsened symptoms, document the model, serial number, and timeline of use. Replacement device claims are reviewed alongside the original recalled device claim.
- Q: Does the FDA consent decree affect my claim?
-
A: The April 2024 consent decree between Philips and the FDA bars Philips from selling new sleep therapy devices in the U.S. through 2029 absent specified compliance milestones. The consent decree is helpful evidence in personal injury claims because it constitutes federal regulatory acknowledgment of the company's failures. It does not directly compensate users; that is what the lawsuit does.
- Q: Can I sue if my loved one died after using a recalled Philips device?
-
A: Yes. Wrongful death claims tied to lung cancer, pulmonary fibrosis, or other recall-linked conditions are part of MDL 3014. Surviving family may pursue both wrongful death damages (for the family's losses) and a survival action (for the decedent's pre-death pain and suffering). See our wrongful death lawyer overview.
- Q: How do I find a Philips CPAP lawyer?
-
A: Most cases are filed directly in MDL 3014 in the W.D. Pa. under the court's direct-filing order. You want a CPAP recall law firm with MDL experience and the resources to litigate, not a local generalist. The case review is free and the contingency fee is standard.
Talk to a Philips CPAP Lawyer Today
If you used a recalled Philips CPAP, BiPAP, or mechanical ventilator and were later diagnosed with cancer, pulmonary fibrosis, reactive airway disease, or another respiratory condition, you may qualify to file in MDL 3014 or through the consolidated settlement program.
The case review is free and confidential. Our team handles CPAP recall cases on contingency. You owe nothing unless we recover for you.
Free Case Evaluation
FILL OUT THE FORM BELOW
TO REQUEST YOUR CASE REVIEW
External Resources
Legal Representation
"Speak with our medical-device attorneys for a free, confidential review of your potential CPAP recall claim. Past results vary based on the unique facts of each case."
Find out more >>